Tech Company M&A Transactions
GlycoFi Acquisition
On 5/9/2006, GlycoFi was bought by Merck. The transaction price was $400 million.
Transaction Overview
Company Name
Acquired By
Announced On
5/9/2006
Transaction Type
M&A
Amount
$400,000,000
M&A Terms
Under the terms of the merger agreement, Merck will acquire 100 percent of the equity of GlycoFi, which will become a wholly-owned subsidiary of Merck & Co, Inc. The all-cash transaction is valued at approximately $400 million and is expected to close in the second quarter of 2006, subject to customary closing conditions and clearance under the Hart-Scott-Rodino Anti-Trust Improvements Act.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
21 Lafayette St. 200
Lebanon, NH 03766
USA
Lebanon, NH 03766
USA
Phone
Website
Email Address
Not Recorded
Overview
GlycoFi, Inc. is the industry leader for the engineering and production of therapeutic glycoproteins in yeast systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charles Hutchinson
Browse more venture capital transactions:
Prev: 5/9/2006: SANcastle Technologies venture capital transaction
Next: 5/10/2006: Trace Checker venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries on this site are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs